please keep our community civil. comments should remain on topic and be respectful.
.
.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
https://grassfed.us/Mancine-neighbour-of-Berryman-from-Vancouver shocking figures uncovered by labour show some patients are suffering agonising waits of as many as 541 days to begin treatment
.
.

.
.